| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Chief Financial Officer | Common Stock | 630,256 | $1,915,978 | $3.04 | 31 Dec 2025 | Direct |
| ORAMED PHARMACEUTICALS INC. | Chief Financial Officer | Performance Stock Units | 19,000 | 31 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | 31 Dec 2025 | 3 | $0 | 4 | Chief Financial Officer | 02 Jan 2026, 20:00 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 11 Feb 2025 | 2 | $0 | 4 | Chief Financial Officer | 11 Feb 2025, 16:30 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 02 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 Jan 2025, 16:10 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 07 Nov 2024 | 1 | $0 | 4 | Chief Financial Officer | 08 Nov 2024, 16:30 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 21 Jun 2024 | 1 | $0 | 4 | Chief Financial Officer | 21 Jun 2024, 16:15 |
| ORMP | ORAMED PHARMACEUTICALS INC. | 18 Jun 2024 | 0 | $0 | 3 | Chief Financial Officer | 21 Jun 2024, 16:10 |
| PHGE | BiomX Inc. | 06 Dec 2023 | 0 | $0 | 3 | Interim CFO | 11 Dec 2023, 16:45 |